Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

AREIT Placement - Expected to Be DPU Accretive but the Acquisition Might Take a While

Ascendas REIT Acquires Second UK Logistics Portfolio

AREIT - Paying for Acquisition with Only Equity Doesn't Add Up, DPU to Fall by 3-4%

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

CapitaLand Ascendas REIT / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/39" target="_blank" data-smartkarma-citation="entities:39:1">Ascendas Real Estate Investment Trust (AREIT SP)</a> plans to raise up to S$155m to fund its acquisition of Australian assets and asset enhancement of a Singapore property. </p><h2>Placement Specifics</h2><ul>
<li>Company Name: Ascendas Real Estate Investment Trust</li>
<li>Ticker: AREIT SP Equity</li>
<li>Primary placement </li>
<li>Settlement is longer than normal, with settlement on 11 Aug, 2016</li>
<li>Indicative deal price -2.34-2.42</li>
<li>Last Traded Price: SGD2.462 (adjusted for advanced distribution)</li>
<li>Advanced Distribution for existing shareholder: S$0.058</li>
<li>…</li>
</ul>

Ascendas Real Estate Investment Trust (AREIT SP) plans to raise up to S$155m to fund its acquisition of Australian assets and asset enhancement of a Singapore property. Placement Specifics
Company Name: Ascendas Real Estate Investment Trust
Ticker: AREIT SP Equity
Primary placement 
Settlement is longer than normal, with settlement on 11 Aug, 2016
Indicative deal price -2.34-2.42
Last Traded Price: SGD2.462 (adjusted for advanced distribution)
Advanced Distribution for existing shareholder: S$0.058
…


AREITへの投資：DPU増加につながる小規模取引